- NEWS
Early tests suggest the protein can be aimed at targets with tumour-causing mutations.
Scientists have exploited a peculiar CRISPR enzyme so that it fights cancer by shredding the DNA in cancer cells, causing them to self-destruct.
doi: https://doi.org/10.1038/d41586-026-02268-z
References
Zeng, J. et al. Nature https://doi.org/10.1038/s41586-026-10738-7 (2026).
Scholz, P. et al. Nature 655, 230–239 (2026).
Dmytrenko, O. et al. Nature 613, 588–594 (2023).
Bravo, J. P. K. et al. Nature 613, 582–587 (2023).
Related Articles
-
CRISPR gets a power boost from AI-designed ‘molecular scissors’
-
CRISPR makes enhanced cancer-fighting immune cells inside mice
-
World first: ultra-powerful CRISPR treatment trialled in a person
-
CRISPR genome-editing grows up: advanced therapies head for the clinic
-
CRISPR cancer trial success paves the way for personalized treatments
Subjects
Latest on:
Jobs
-
Postdoctoral fellowship in neurogenomics
NIH postdoctoral fellowship opportunity in neurogenomics, multi-omics, and computational biology of neurodegenerative diseases.
National Institute of Health, Bethesda
National Institutes of Health (NIH)
-
-
-
-
Research Scientist in AI for Healthcare
The post-holder will play a key role in OSCAR's research, supervised by Prof. Clifton, Chair of Clinical Machine Learning, University of Oxford.
Suzhou, Jiangsu (CN)
Oxford Suzhou Centre for Advanced Research